Hodgkin Lymphoma | Lymphoma | Non-Hodgkin’s Lymphoma | Peripheral T-cell Lymphoma | Cutaneous T-cell Lymphoma | Diffuse Large B Cell Lymphoma | |
---|---|---|---|---|---|---|
brentuximab vedotin | ||||||
AFM13 | ||||||
TT11 | ||||||
gemcitabine + doxorubicin hydrochloride | ||||||
nivolumab + brentuximab vedotin | ||||||
brentuximab vedotin + SGN-CD30C | ||||||
BV-ICE | ||||||
CD30-targeted CAR-T immunotherapy | ||||||
T-lymphocyte cell therapy | ||||||
McSAF 02 |